U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
165241165241Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.CompletedNo Results AvailableChoroidal NeovascularizationDrug: ranibizumabhttps://ClinicalTrials.gov/show/NCT00395551
165242165242Effects of PTH Replacement on Bone in HypoparathyroidismActive, not recruitingNo Results AvailableHypoparathyroidism|DiGeorge SyndromeDrug: PTH 1-34https://ClinicalTrials.gov/show/NCT00395538
165243165243Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCompletedHas ResultsDiabetes MellitusDrug: Alogliptin|Drug: Pioglitazone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00395512
165244165244Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and SalivaCompletedNo Results AvailablePatients Already Taking Risperidone for Clinical IndicationsDrug: Risperidonehttps://ClinicalTrials.gov/show/NCT00395499
165245165245ROMEO (Rosuvastatin in Metabolic syndrOme)CompletedHas ResultsMetabolic Syndrome XDrug: Rosuvastatin|Drug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT00395486
165246165246Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)CompletedNo Results AvailableHypercholesterolemiaDrug: MK0653, ezetimibe / Duration of Treatment: 6 Weekshttps://ClinicalTrials.gov/show/NCT00395473
165247165247Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese PatientsCompletedHas ResultsCentral Nervous System DiseasesDrug: Gadobutrol (Gadavist, Gadovist, BAY86-4875)|Drug: Magnevisthttps://ClinicalTrials.gov/show/NCT00395460
165248165248REPLACE: Implantable Cardiac Pulse Generator Replacement RegistryCompletedHas ResultsDevice Replacement|Elective Replacement (ERI)|Device Advisory|Device Upgrade|Postoperative ComplicationsProcedure: Straight-forward Device Replacement|Procedure: Device Replacement with Upgradehttps://ClinicalTrials.gov/show/NCT00395447
165249165249Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid TumorsCompletedNo Results AvailableTumorsDrug: Combretastatin A4 Phosphate (CA4P)|Drug: Bevacizumab (Avastin)https://ClinicalTrials.gov/show/NCT00395434
165250165250Study to Evaluate Drug-drug Interaction Between Valopicitabine and RibavirinCompletedNo Results AvailableChronic Hepatitis CDrug: NM283 plus Peg-IFNα-2ahttps://ClinicalTrials.gov/show/NCT00395421
165251165251Linear Growth Study (0476-097)(COMPLETED)CompletedNo Results AvailableAsthmaDrug: MK0476, montelukast sodium / Duration of Treatment : 56 Weeks|Drug: Comparator : beclomethasone dipropionate / Duration of Treatment : 56 Weekshttps://ClinicalTrials.gov/show/NCT00395408
165252165252Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal WomenCompletedNo Results AvailablePostmenopausal OsteoporosisDrug: Oral salmon calcitonin, salmon calcitonin nasal sprayhttps://ClinicalTrials.gov/show/NCT00395395
165253165253Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney DiseaseCompletedNo Results AvailableVascular Calcification|ArteriosclerosisDrug: Alendronate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00395382
165254165254Effect of Intraoperative Aprotinin Administration on Post Cardiac Surgery Optic Nerve and Retinal Thickness.Not yet recruitingNo Results AvailableCardiac SurgeryDrug: intraoperative aprotinin administrationhttps://ClinicalTrials.gov/show/NCT00395369
165255165255Efficacy and Feasibility of an Intermittent Weight Loss Program.CompletedNo Results AvailableObesityBehavioral: calorie controlled diethttps://ClinicalTrials.gov/show/NCT00395356
165256165256Sitagliptin Added-on to Insulin Study (0431-051)CompletedHas ResultsType 2 Diabetes MellitusDrug: sitagliptin phosphate|Drug: Comparator : placebo (unspecified)https://ClinicalTrials.gov/show/NCT00395343
165257165257Airways Dysfunction Following WTC Dust ExposureCompletedNo Results AvailablePulmonary Diseaseshttps://ClinicalTrials.gov/show/NCT00395330
165258165258Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)CompletedNo Results AvailableMultiple SclerosisOther: Placebo|Drug: Firategrast 150 mg|Drug: Firategrast 300 mghttps://ClinicalTrials.gov/show/NCT00395317
165259165259Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)CompletedHas ResultsAsthmaDrug: fluticasone propionate + montelukast|Drug: fluticasone propionate|Drug: fluticasone propionate + salmeterolhttps://ClinicalTrials.gov/show/NCT00395304
165260165260Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD PatientsCompletedHas ResultsChronic Kidney Disease|End Stage Renal DiseaseDrug: MK-0677|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00395291
165261165261Development of Serologic Assays for Human Herpes Virus-8Active, not recruitingNo Results AvailableHerpesvirus 8, Humanhttps://ClinicalTrials.gov/show/NCT00395278
165262165262Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic SyndromeCompletedNo Results AvailableVenous Thrombosis|Venous Insufficiencyhttps://ClinicalTrials.gov/show/NCT00395265
165263165263Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic CancerCompletedNo Results AvailableAdenocarcinomaDrug: Cetuximab (Erbitux®) and Gemcitabinehttps://ClinicalTrials.gov/show/NCT00395252
165264165264Asthma/Steroid Withdrawal StudyActive, not recruitingNo Results AvailableAsthmaDrug: inhaled corticosteroidhttps://ClinicalTrials.gov/show/NCT00395239
165265165265Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled TrialTerminatedHas ResultsRosaceaDrug: zinc sulfate|Drug: placebohttps://ClinicalTrials.gov/show/NCT00395226
165266165266Antidepressant Safety in Kids StudyCompletedNo Results AvailableAnxiety Disorders|Depressive Disorders|Eating Disorders|Obsessive Compulsive DisorderDrug: Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medicationshttps://ClinicalTrials.gov/show/NCT00395213
165267165267Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)CompletedNo Results AvailableMultiple SclerosisProcedure: MSC Treatmenthttps://ClinicalTrials.gov/show/NCT00395200
165268165268A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis SuppurativaCompletedNo Results AvailableHidradenitis SuppurativaProcedure: Photodynamic Therapyhttps://ClinicalTrials.gov/show/NCT00395187
165269165269Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly AdultsCompletedNo Results AvailableInfluenzaBiological: Influenza Vaccinationhttps://ClinicalTrials.gov/show/NCT00395174
165270165270The CRISIS Prevention StudyTerminatedHas ResultsSepsisDrug: Metoclopramide|Drug: Zinc|Dietary Supplement: Glutamine|Drug: Selenium|Other: saline|Other: sterile water|Other: selenium|Dietary Supplement: whey-proteinhttps://ClinicalTrials.gov/show/NCT00395161

* Görseller ve İçerik tekif hakkına sahip olabilir